8-Fluoro-5-((2-Fluoro-18F)Ethyl)-5,6-Dihydro-6-Oxo-4H-Imidazo(1,5-a)(1,4)Benzodiazepine-3-Carboxylic Acid Ethyl Ester

CAS : 143693-57-6

Ref. 3D-FF103276

Informations sur le produit

• Nom: 8-Fluoro-5-((2-Fluoro-18F)Ethyl)-5,6-Dihydro-6-Oxo-4H-Imidazo(1,5-a)(1,4)Benzodiazepine-3-Carboxylic Acid Ethyl Ester
• Synonymes: 5-(2'-(18F)Fluoroethyl)flumazenil, (18F)Fluoroethylflumazenil, 4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5-((2-fluoro-18F)ethyl)-5,6-dihydro-6-oxo-, ethyl ester, ethyl 8-fluoro-5-[2-(~18~F)fluoroethyl]-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate, 5-(2'-Fluoroethyl)flumazenil

Description

8-Fluoro-5-(2-fluoro-18F)ethyl)-5,6-dihydro-6-oxo-4H-imidazo(1,5a)(1,4)benzodiazepine 3-carboxylic acid ethyl ester is a synthetic radioligand that binds to the benzodiazepine receptor. It has been used as a research tool for studying the binding of benzodiazepines to receptors in humans and animals. 8F-[18F]EFDZCAE is an unlabelled positron emission tomography (PET) imaging agent that can be used for the diagnosis of hepatic diseases. PET scans with 8F-[18F]EFDZCAE are currently being used clinically in patients with epilepsy or other neurological disorders.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 335.31 g/mol
• Formule: C₁₆H₁₅F₂N₃O₃
• Degré de pureté: Min. 95%